Priti Jayesh Bhayani

Title: Priti Jayesh Bhayani: Innovator in Pharmaceutical Chemistry

Introduction

Priti Jayesh Bhayani, a distinguished inventor from Maharashtra, India, has made significant contributions to the field of pharmaceutical chemistry. Known for her innovative approach, she holds a patent that enhances the synthesis of a crucial drug component used in the treatment of cardiovascular conditions.

Latest Patents

Priti Bhayani's patent focuses on an "Industrial process for preparation of Clopidogrel hydrogen sulphate". This novel methodology offers an improved process for manufacturing Clopidogrel, originating from 2-(2-thienyl) ethylamine. By eliminating the need to isolate an unstable intermediate, her method employs a one-pot cyclization to produce 4, 5, 6, 7-tetrahydrothieno (3,2-c) pyridine. This compound is subsequently reacted with halo-compounds at temperatures ranging from 20 to 90°C, utilizing solvents such as water and dichloroethane in the presence of organic or inorganic bases. Additionally, her invention discloses a process for resolving racemic Clopidogrel into its optical antipodes and converting the dextroclopidogrel base into known polymorphs.

Career Highlights

Priti currently works at Ipca Laboratories Limited, a reputable company in the pharmaceutical industry. With a strong background in chemical processes, she has continuously strived to innovate and develop new methodologies that simplify complex processes within drug manufacturing. Her dedication to advancing pharmaceutical chemistry is commendable and reflects her commitment to improving therapeutic outcomes.

Collaborations

Throughout her career, Priti has collaborated with esteemed colleagues such as Ashok Kumar and Ketan Dhansukhlal Vyas. These collaborations have facilitated sharing of knowledge, expertise, and resources, further enhancing the innovative spirit within her team at Ipca Laboratories Limited.

Conclusion

Priti Jayesh Bhayani is a remarkable inventor in the realm of pharmaceutical innovations. Her patented process not only simplifies the preparation of a vital drug component but also emphasizes her commitment to advancing healthcare solutions. As she continues her work at Ipca Laboratories Limited, her contributions will undoubtedly have lasting impacts on the pharmaceutical industry and patient care.